- advertising -

Silab develops a 3D model that mimics acne-prone skin

Silab Softcare's advanced research teams have developed a 3D model of reconstructed epidermis that mimics in vitro acneic skin. The characterization of this model has just been published by the scientific journal Experimental Dermatology*.

Acne is an inflammatory skin disease involving four essential components: hyperseborrhea combined with a change in sebum composition, colonization by Cutibacterium (C.) acnes and in particular the virulent phylotype IA1, hyperkeratinization and secreted inflammation.

Most 3D models mimicking acneic skin independently use hyperseborrhea or invasion by C. acnes to induce the different characteristics of acneic skin. However, as these two factors are dependent on each other in the early stages of the pathology, the aim of this study was to develop a 3D model combining sebum alteration and invasion by C. acnes.

Thus, a reconstructed epidermis was treated with peroxidized squalene and the IA1 phylotype of C. acnesThe combination of these two factors allowed the induction of acne-related keratinocyte responses such as hyperkeratinization and inflammation. The combination of these two factors allowed the induction of keratinocyte responses related to acne such as hyperkeratinization and inflammation, and thus obtaining a model with all the characteristics of acneic skin.

"The extensive characterization of this new model in vitro has proven that it is fully adapted to mimic acne-prone skin and serve as a screening tool for the development of anti-acne treatments.says Marine Laclaverie, Innovation Project Manager in vitroSilab.

Acnesium, the daily care for acne-prone skin

The 3D model obtained during this study has allowed to demonstrate the pharmacological activities of Acnesium, a natural active ingredient developed by Silab Softcare to treat the clinical signs of mild to moderate acne in adults.

Produced from immature pomegranate bark, Acnesium restores homeostasis to acne-prone skin by targeting the four major components of this pathophysiology: it normalizes sebaceous gland activity, controls colonization by the IA1 phylotype of C. acnesIt has a keratolytic action and reduces inflammation. Combining speed of action and effectiveness, this high-tolerance treatment improves the general appearance of the skin and thus the quality of life of patients.

* Laclaverie et al, Development and characterization of a 3D in vitro model mimicking acneic skin, Experimental Dermatology (https://doi.org/10.1111/exd.14268) Experimental Dermatology; Impact factor 3.368; Ranking 15/146 in Dermatology

External resources
silab.fr

Sponsored content

site-industries-cosmetiques A long-haired woman smiles outdoors. Text: "Holistic beauty study with Cerebiome® for skin", with icons, a Draft banner and "Nutra Ingredients Awards 2025 Finalist". The Lallemand Health Solutions logo is visible.

Lallemand Health Solutions named finalist for 'Ingredient of the year' award

Lallemand Health Solutions is proud to announce that it has been shortlisted for the 2025 NutraIngredients Awards in two of the 16 categories.
site-industries-cosmetiques A smiling woman with long hair stands in an open field. The text reads: "See you at in-cosmetics global, April 8-10 in Amsterdam, stand 11J41. Discover the Holistic Beauty Study with Cerebiome® for skin health." The Lallemand logo is visible in the bottom corner.

New publication with Cerebiome® for the intestine-brain-skin axis

Lallemand Health Solutions' innovative formula shows benefits for occasional stress, sleep quality and skin appearance.

Related articles

Our last issue

Listen to us!

Newsletter

en_USEnglish